See how these people are conquering their health challenges in Florida
Florida residents are confronting serious health challenges with support from medical teams, community groups and new technology.
Outreach workers from the Miami-Dade County Homeless Trust provide water and cooling supplies to those most affected by the city's record heat, while WeCount! advocates for better protections for outdoor workers.
Survivors of recent hurricanes in Miami face invisible mental health hurdles, as experts from virtual platforms like Nema Health teach people to recognize and treat PTSD through talk therapies such as cognitive processing therapy.
Meanwhile, stroke survivors find renewed hope with Miami's first use of nerve stimulation devices, which help patients regain movement years after their initial injury. Across these tough situations, Miami's residents and organizations work to adapt, recover and support each other.
Arlet Lara, the first patient in South Florida to get an FDA-approved nerve stimulation implant, does an exercise while Neil Batungbakal, rehabilitation therapist, activates the implant with the black trigger during her physical therapy appointment on Monday, Sept. 9, 2024, at Lynn Rehabilitation Center at Jackson Memorial Hospital. The activation works as positive reinforcement to her muscles when she completes the exercise correctly.
NO. 1: A STROKE CHANGED A MIAMI TEACHER'S LIFE. HOW A NEW ELECTRICAL DEVICE IS HELPING HER MOVE
What to know about how it works. | Published November 18, 2024 | Read Full Story by Michelle Marchante
Jean Wilfred, 70, enjoys a bottle of water as the outreach team from the Miami-Dade Homeless Trust handed out bottles of water to individuals living on the street on Aug. 1, 2024, in Miami, Florida, during a period of sweltering heat. By Carl Juste
NO. 2: 'WE NEED WATER.' HOW SOUTH FLORIDA GROUPS ARE HELPING THOSE HARDEST HIT BY EXTREME HEAT
Miami-area nonprofits are helping those most vulnerable to the extreme heat South Florida is facing. | Published October 30, 2024 | Read Full Story by Mimi Whitefield
Juan Jose Muñoz (left) and Elvin Antonio Urbina walk with her belongings through the flooded N 15th St in North Tampa, Thursday, October 10, 2024, a day after Hurricane Milton crossed Florida's Gulf Coast. By Pedro Portal
NO. 3: FLORIDIAN HURRICANE SURVIVORS COULD BE SUFFERING FROM PTSD—BUT RECOVERY IS POSSIBLE
After a tumultuous hurricane season, an expert says Floridians should look out for symptoms of PTSD. | Published November 27, 2024 | Read Full Story by Denise Hruby
The summary above was drafted with the help of AI tools and edited by journalists in our News division. All stories listed were reported, written and edited by McClatchy journalists.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
CRISPR and Lab-on-a-Chip Technologies Set to Revolutionize Pathogen Detection
The Global Food Pathogen Testing Market, valued at USD 10 billion in 2025, is projected to grow at a CAGR of 10%, reaching USD 23.5 billion by 2034. Growing food safety concerns and advancements in rapid testing methods, AI, and blockchain are driving this expansion, optimizing food supply chain transparency. Food Pathogen Testing Market Dublin, July 04, 2025 (GLOBE NEWSWIRE) -- The "Food Pathogen Testing Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and Challenges" report has been added to Food Pathogen Testing Market is valued at USD 10 billion in 2025. Further, the market is expected to grow at a CAGR of 10% to reach USD 23.5 billion by 2034. The Food Pathogen Testing Market is expanding rapidly as global food safety concerns continue to intensify. With rising instances of foodborne illnesses and outbreaks caused by bacteria such as Salmonella, Listeria, and E. coli, food manufacturers and regulatory authorities are prioritizing stringent testing protocols. Food pathogen testing plays a crucial role in ensuring the safety and quality of food products by detecting harmful microorganisms at various stages of production, processing, and distribution. Regulatory frameworks across regions, including the FDA's Food Safety Modernization Act (FSMA) in the U.S. and the European Union's strict food safety directives, are pushing companies to adopt advanced testing in rapid testing methods, including polymerase chain reaction (PCR) and immunoassay-based techniques, are enabling faster and more accurate pathogen detection. Additionally, the growing consumption of processed and packaged foods, along with increased global trade in perishable goods, is further propelling market demand. As food safety regulations become stricter worldwide, investment in food pathogen testing technologies and automation is expected to grow 2024, the Food Pathogen Testing Market has witnessed several key advancements driven by the growing emphasis on foodborne disease prevention. The demand for rapid and automated testing solutions has increased, with food manufacturers investing in next-generation molecular diagnostics and biosensors to achieve quicker turnaround times. AI-driven predictive analytics are being integrated into testing processes to enhance contamination risk assessments and prevent outbreaks before they occur. Regulatory bodies worldwide have intensified surveillance and enforcement, leading to a higher rate of recalls and penalties for expansion of microbiological testing services in developing economies, particularly in Asia-Pacific and Latin America, has also gained momentum due to increased food exports and a growing middle-class population demanding higher food safety standards. Meanwhile, the adoption of blockchain technology in food supply chains is improving traceability and ensuring transparency in pathogen testing, allowing for swift action in case of contamination. The market is also experiencing a shift toward portable testing kits that enable on-site detection, reducing dependency on centralized ahead to 2025 and beyond, the Food Pathogen Testing Market is expected to see further advancements in automation, precision, and regulatory alignment. AI and machine learning will play a more significant role in predictive food safety monitoring, helping manufacturers identify contamination risks before they escalate into widespread issues. The development of CRISPR-based diagnostics is set to revolutionize pathogen detection by providing ultra-sensitive and rapid testing solutions. Additionally, the rise of lab-on-a-chip technology will enable decentralized testing, making food safety monitoring more accessible and the increasing focus on sustainability, manufacturers will also seek eco-friendly testing solutions that minimize chemical waste and energy consumption. Governments and international organizations will likely standardize food safety regulations further, ensuring consistency across borders and streamlining compliance processes. As food production scales up to meet global demand, investments in robust pathogen testing infrastructure will become essential for ensuring public health and maintaining consumer trust in food Trends in the Food Pathogen Testing Market Adoption of AI and Big Data Analytics: AI-driven predictive modeling is being integrated into pathogen testing to analyze contamination patterns, optimize food safety protocols, and minimize risks before they lead to outbreaks. Rise of Rapid and Portable Testing Solutions: The demand for on-site pathogen testing kits is increasing, enabling food manufacturers and regulators to conduct immediate contamination assessments and reduce response times. Integration of Blockchain in Food Safety: Blockchain technology is enhancing traceability and transparency in food supply chains, ensuring accurate record-keeping and quick identification of contamination sources. Expansion of CRISPR-Based Pathogen Detection: Emerging CRISPR diagnostic technologies are offering ultra-fast and precise detection of harmful foodborne pathogens, promising a new era of molecular food safety testing. Growth of Outsourced Testing Services: Many food companies are partnering with third-party laboratories for pathogen testing, ensuring compliance with evolving regulatory requirements while reducing in-house testing costs. Key Market Drivers Increasing Foodborne Illness Outbreaks: Rising global cases of foodborne diseases are driving the demand for stringent pathogen testing measures to ensure consumer safety and prevent large-scale outbreaks. Stringent Government Regulations: Enhanced regulatory frameworks across regions are compelling food manufacturers to comply with mandatory pathogen testing standards, increasing market growth. Surge in Packaged and Processed Food Consumption: The growing consumption of ready-to-eat and processed foods necessitates rigorous testing to ensure microbiological safety and extend shelf life. Technological Advancements in Testing Methods: Innovations in molecular diagnostics, biosensors, and AI-powered analytics are improving pathogen detection efficiency, making testing faster and more reliable. Key Market Challenge High Cost of Advanced Testing Technologies: The implementation of sophisticated pathogen testing solutions, such as molecular diagnostics and AI-driven analytics, involves significant investment, posing challenges for small and mid-sized food businesses. Key Attributes: Report Attribute Details No. of Pages 150 Forecast Period 2025 - 2034 Estimated Market Value (USD) in 2025 $10 Billion Forecasted Market Value (USD) by 2034 $23.5 Billion Compound Annual Growth Rate 10.0% Regions Covered Global Companies Featured Bureau Veritas SA Lloyd's Register Quality Assurance Limited Intertek Group plc Asurequality Ltd. Genevac Ltd. Thermo Fisher Scientific Inc. Bio-Rad Laboratories Inc. Merck Co. & KGaA Neogen Corporation bioMerieux SA Agilent Technologies Inc. Qiagen NV Shimadzu Corporation SGS Societe Generale de Surveillance SA Genetic Id Na Inc. RapidBio Systems Inc. Merieux NutriSciences Corp. FoodChain ID Inc. Ring Biotechnology Co. Ltd. Genon Laboratories Ltd. PerkinElmer Inc. Randox Food Diagnostics Ltd. Omega Diagnostics Group plc Romer Labs Inc. Eurofins Scientific SE Charm Sciences Inc. Hygiena LLC MilliporeSigma Hardy Diagnostics Luminex Corporation Market Segmentation By Type Salmonella Listeria Other Pathogens By Technology Traditional Rapid Immunoassay Convenience Based PCR Other Technologies By Application Meat And Poultry Fruits And Vegetables Dairy Other Applications By Sales Channel OEM Aftermarket By Geography North America (USA, Canada, Mexico) Europe (Germany, UK, France, Spain, Italy, Rest of Europe) Asia-Pacific (China, India, Japan, Australia, Vietnam, Rest of APAC) The Middle East and Africa (Middle East, Africa) South and Central America (Brazil, Argentina, Rest of SCA) For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Food Pathogen Testing Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Miami Herald
an hour ago
- Miami Herald
What's messing with our health and well-being in Miami? Take a look
Health Care What's messing with our health and well-being in Miami? Take a look These articles highlight various health challenges people face in Miami. One discussion focuses on how disrupted sleep can affect brain health. Another article addresses women's healthcare issues in Florida, ranking the state poorly due to healthcare cost and accessibility problems. In the aftermath of hurricanes, there's a concern for PTSD among survivors. See stories below. NO. 1: WHAT'S WRONG WITH YOUR BRAIN? IT COULD COME DOWN TO WHAT YOU NEED MORE OF EACH NIGHT Here is some expert medical advice. | Published June 5, 2024 | Read Full Story by Michelle Marchante Florida's healthcare system has 'worse-than-average performance' for women, according to a 2024 report. By Carl Juste NO. 2: WHY IS WOMEN'S HEALTHCARE IN A 'PERILOUS PLACE'? TAKE A LOOK AT THE FLORIDA RANKINGS Women in the state are struggling with health issues and access. | Published July 25, 2024 | Read Full Story by Adlai Coleman Juan Jose Muñoz (left) and Elvin Antonio Urbina walk with her belongings through the flooded N 15th St in North Tampa, Thursday, October 10, 2024, a day after Hurricane Milton crossed Florida's Gulf Coast. By Pedro Portal NO. 3: FLORIDIAN HURRICANE SURVIVORS COULD BE SUFFERING FROM PTSD—BUT RECOVERY IS POSSIBLE After a tumultuous hurricane season, an expert says Floridians should look out for symptoms of PTSD. | Published November 27, 2024 | Read Full Story by Denise Hruby The summary above was drafted with the help of AI tools and edited by journalists in our News division. All stories listed were reported, written and edited by McClatchy journalists.
Yahoo
an hour ago
- Yahoo
GE HealthCare's Vizamyl Receives Expanded FDA Approval for Quantitative Alzheimer's Amyloid Detection
GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the best up and coming stocks to invest in now. On June 24, On June 24, 2025, GE HealthCare announced that the US FDA approved an updated label for its Vizamyl (flutemetamol F 18 injection) PET imaging agent, which is used for beta-amyloid detection. The immediate update expands the agent's indications, which allows for quantitative analysis of Vizamyl scans, and removes several prior limitations. Previously, amyloid diagnostics like Vizamyl provided a visual assessment of amyloid plaque in the brain. With the new label, clinicians can now use quantitative analysis software to objectively calculate amyloid load. A radiologist in a lab examining a computed tomography scan of a patient. The removal of the therapy monitoring limitation means Vizamyl can now be used to determine if amyloid plaque levels have sufficiently reduced to consider discontinuing therapy. The updated label also explicitly indicates Vizamyl's use for selecting patients eligible for anti-amyloid therapy. Vizamyl was initially approved in 2013 to estimate beta-amyloid neuritic plaque density in adults with cognitive impairment. GE HealthCare Technologies Inc. (NASDAQ:GEHC) develops, manufactures, and markets products, services, and digital solutions used in the diagnosis, treatment, and monitoring of patients. While we acknowledge the potential of GEHC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
